OncLiveOnAir,lysm,oncology

Mashup Score: 2

Explore Findings With Nivolumab Plus AVD in Advanced-Stage Classic Hodgkin Lymphoma: With Alex F. Herrera, MD - 12 hour(s) ago

Dr Herrera explains why N+AVD is a strong candidate for primary treatment in adolescent and adult patients with stage III or IV Hodgkin lymphoma.

Source: www.onclive.com

Categories: General Medicine News, Oncologists1

Tweet Tweets with this article
- OncLive
  
  ICYMI: Alex Herrera, MD, of @cityofhope details longer-term follow-up results from the phase 3 SWOG S1826 trial of N+AVD vs BV+AVD for patients with stage III/IV Hodgkin lymphoma. Listen to the full interview here: https://t.co/h4ES1lBfT1 #OncLiveOnAir #lysm #oncology https://t.co/OYWz9CiVnN